NEW HAVEN, Conn., May 18, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced the promotion of Gautam Shah, Ph.D. to Executive Vice President. Dr. Shah maintains his position as Chief Compliance Officer; he had previously served as Senior Vice President.
